Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immune Therapeutics, Inc. (IMUN) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immune Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1559356.
Total stock buying since 2016: $18,405.
Total stock sales since 2016: $0.
Total stock option exercises since 2016: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2023 | 409,000 | $18,405 | 0 | $0 | 0 | $0 |
2016 | 3,000,000 | $0 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2023-02 | 409,000 | $18,405 | 0 | $0 | 0 | $0 |
2016-07 | 3,000,000 | $0 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-02-10 | Farmer Glen A (Chief Financial Officer) | Buy | 409,000 | .04 | 18,405 |
2016-07-18 | Griffin Noreen (CHIEF EXECUTIVE OFFICER) | Buy | 3,000,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of IMUN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immune Therapeutics, Inc. (symbol IMUN, CIK number 1559356) see the Securities and Exchange Commission (SEC) website.